Whole Exome Sequencing Market Size, Share, Growth, Forecast 2030

Whole Exome Sequencing Market

Whole Exome Sequencing Market Technology (Sequencing by Synthesis, Sequencing by Ion Semiconductor, and Others), Product (Sequencing Instruments, Sequencing Services, Kits, Data Analysis Services, and Others), Application (Personalized Medicine, Diagnostics, Agriculture and Animal Research, Drug Discovery and Development, and Others), and End-User (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Research Center, Academic and Government Institutions, and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2026

Category: Chemical & Materials Report Format : PDF Pages: 110 Report Code: ZMR-278 Published Date: Oct-2020 Status : Published
Market Size in 2019 Market Forecast in 2026 CAGR (in %) Base Year
USD 1,075 million USD 4,325 million 22% 2020

According to the report published by Zion Market Research, global demand for the whole exome sequencing market was valued at approximately USD 1,075 Million in 2019, and is expected to generate revenue of around USD 4,325 Million by end of 2026, growing at a CAGR of around 22% between 2020 and 2026.

The report analyzes the global whole exome sequencing market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the whole exome sequencing industry.

Global Whole Exome Sequencing Market: Overview

Whole exome sequencing is a technology that causes a complete DNA sequence of any organism’s genome at a single time through the help of various laboratory processes. In the future of personalized medicine, the whole genome sequence will play an important role in guiding the therapeutic intervention. Currently, it is being widely used for the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s disease.

Global Whole Exome Sequencing Market: Growth Factors

Cost-effectiveness with the whole exome sequencing as compared with whole-genome sequencing along with global alliances among key research facilities are some of the factors that increase the demand of the global whole exome sequencing market. Apart from this, the increasing population along with rising incidences of cancer and other infectious diseases are also boosting the growth of the global market. In addition, high investments by companies, both new and old, are on R&D facilities in this technology is also impacting the growth of the market in a positive way. However, lack of skilled manpower and professionals and dependency on the government authorities for approvals and grants are the factors restraining the growth of the market.

Global Whole Exome Sequencing Market Request Free Sample

Global Whole Exome Sequencing Market: Segmentation

On the basis of technology, the global whole exome sequencing market is segmented as sequencing by synthesis, sequencing by ion semiconductor, and others. Based on the products, the market is segmented as sequencing instruments, sequencing services, kits, data analysis services, and others. Sequencing kits are segmented into end repair, DNA fragmentation, A-Tailing and size selection, target enrichment kit and library preparation kits. On the basis of applications, the global market is classified into personalized medicine, diagnostics, agriculture and animal research, drug discovery and development, and others. Based on the end-users segment, the market is divided further into pharmaceutical and biotechnology companies, hospitals and clinics, research centers, academic and government institutions, and others.

Region-wise, the global market is segregated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Global Whole Exome Sequencing Market: Competitive Players

Some most important players of the global whole exome sequencing market are BGI, Ambry Genetics, Eurofins Genomics, Inc., Life Technologies, Illumina, Inc., GENEWIZ, Inc, Roche NimbleGen, Inc., Agilent Technologies, Knome, Inc., and Macrogen, Inc., among others.

Whole Exome Sequencing Market: Report Scope

Report Attributes Report Details
Report Name Whole Exome Sequencing Market Research Report
Market Size in 2022 USD 1,075 Million
Market Forecast in 2030 USD 4,325 Million
Growth Rate CAGR of 22%
Number of Pages 210
Key Companies Covered BGI, Ambry Genetics, Eurofins Genomics, Inc., Life Technologies, Illumina, Inc., GENEWIZ, Inc, Roche NimbleGen, Inc., Agilent Technologies, Knome, Inc., and Macrogen, Inc
Segments Covered By Product, By Application, By End User, By Technology and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2020
Historical Year 2016 to 2020
Forecast Year 2021 - 2028
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Global Whole Exome Sequencing Market: Regional Analysis

Based on regions, the global Whole Exome Sequencing market can be divided into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America is the largest market for whole exome sequencing owing to scientific awareness, advanced technology, sufficient funds available at disposal, and the interest of the government and private organizations in developing this method and making it more cost-effective. This trend is followed by Europe and Asia. Asia is anticipated to grow at a considerable rate in the near future.

Global Whole Exome Sequencing Market SizeRequest Free Sample

Regular government funding and a large number of conferences on the subject of whole exome sequencing technology and methods are a few of the major factors boosting the growth of the market in this region.

Whole Exome Sequencing Market: Competitive Analysis

The global Whole Exome Sequencing market is dominated by players like:

  • BGI
  • Ambry Genetics
  • Eurofins Genomics, Inc
  • Life Technologies
  • Illumina, Inc
  • GENEWIZ, Inc
  • Roche NimbleGen, Inc
  • Agilent Technologies
  • Knome, Inc.
  • Macrogen, Inc

The global Whole Exome Sequencing market is segmented as follows:

By Product

  • Sequencing instruments
  • Sequencing services
  • Kits
  • Data analysis services
  • Others

By Application

  • Personalized medicine
  • Diagnostics
  • Agriculture and animal research
  • Drug discovery and development
  • Others

By End User

  • Pharmaceutical and biotechnology companies
  • Hospitals and Clinics
  • Research centers
  • Academic and government institutions
  • Others

By Technology

  • Sequencing by synthesis
  • Sequencing by ion semiconductor
  • Others

Whole Exome Sequencing Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

Methodology

FrequentlyAsked Questions

Cost-effectiveness with the whole exome sequencing as compared with whole-genome sequencing along with global alliances among key research facilities are some of the factors that increase the demand of the global whole exome sequencing market. Apart from this, the increasing population along with rising incidences of cancer and other infectious diseases are also boosting the growth of the global market.

According to Zion Market Research, the global demand for the whole exome sequencing market is expected to generate revenue of around USD 4,325 Million by end of 2026, growing at a CAGR of around 22% between 2020 and 2026.

North America is the largest market for whole exome sequencing owing to scientific awareness, advanced technology, sufficient funds available at disposal, and the interest of the government and private organizations in developing this method and making it more cost-effective.

Some main participants of the whole exome sequencing market are BGI, Ambry Genetics, Eurofins Genomics, Inc., Life Technologies, Illumina, Inc., GENEWIZ, Inc, Roche NimbleGen, Inc., Agilent Technologies, Knome, Inc., and Macrogen, Inc., among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed